JPH044308B2 - - Google Patents
Info
- Publication number
- JPH044308B2 JPH044308B2 JP62072589A JP7258987A JPH044308B2 JP H044308 B2 JPH044308 B2 JP H044308B2 JP 62072589 A JP62072589 A JP 62072589A JP 7258987 A JP7258987 A JP 7258987A JP H044308 B2 JPH044308 B2 JP H044308B2
- Authority
- JP
- Japan
- Prior art keywords
- lysine
- phenylpropyl
- formula
- carboxy
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 ethoxycarbonyl-3-oxo-3-phenylpropyl Chemical group 0.000 claims description 22
- 239000004472 Lysine Substances 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 14
- 239000002585 base Substances 0.000 claims description 13
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 125000006239 protecting group Chemical group 0.000 claims description 11
- 150000008545 L-lysines Chemical class 0.000 claims description 10
- 230000003197 catalytic effect Effects 0.000 claims description 9
- PLPDHGOODMBBGN-UHFFFAOYSA-N 4-oxo-4-phenylbut-2-enoic acid Chemical class OC(=O)C=CC(=O)C1=CC=CC=C1 PLPDHGOODMBBGN-UHFFFAOYSA-N 0.000 claims description 8
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- PZZHRSVBHRVIMI-YFKPBYRVSA-N N(6)-trifluoroacetyl-L-lysine Chemical compound OC(=O)[C@@H](N)CCCCNC(=O)C(F)(F)F PZZHRSVBHRVIMI-YFKPBYRVSA-N 0.000 claims description 5
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 238000007259 addition reaction Methods 0.000 claims description 4
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims description 4
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 4
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- ACXLBHHUHSJENU-CMDGGOBGSA-N ethyl (e)-4-oxo-4-phenylbut-2-enoate Chemical compound CCOC(=O)\C=C\C(=O)C1=CC=CC=C1 ACXLBHHUHSJENU-CMDGGOBGSA-N 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 1
- 239000000908 ammonium hydroxide Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 49
- 238000006243 chemical reaction Methods 0.000 description 37
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-Lysine Natural products NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 24
- 229960003646 lysine Drugs 0.000 description 17
- 238000000034 method Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 12
- 235000018977 lysine Nutrition 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 5
- 239000003513 alkali Substances 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 4
- 125000004344 phenylpropyl group Chemical group 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- CKGCFBNYQJDIGS-LBPRGKRZSA-N (2s)-2-azaniumyl-6-(phenylmethoxycarbonylamino)hexanoate Chemical compound [O-]C(=O)[C@@H]([NH3+])CCCCNC(=O)OCC1=CC=CC=C1 CKGCFBNYQJDIGS-LBPRGKRZSA-N 0.000 description 3
- KNCHTBNNSQSLRV-YFKPBYRVSA-N (2s)-6-amino-2-[(2,2,2-trifluoroacetyl)amino]hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)C(F)(F)F KNCHTBNNSQSLRV-YFKPBYRVSA-N 0.000 description 3
- PLPDHGOODMBBGN-VOTSOKGWSA-N (e)-4-oxo-4-phenylbut-2-enoic acid Chemical compound OC(=O)\C=C\C(=O)C1=CC=CC=C1 PLPDHGOODMBBGN-VOTSOKGWSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000019766 L-Lysine Nutrition 0.000 description 3
- 108010007859 Lisinopril Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006845 Michael addition reaction Methods 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229960002394 lisinopril Drugs 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 238000010647 peptide synthesis reaction Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- XXAYGJGDVLSEML-LBPRGKRZSA-N benzyl (2s)-2,6-diaminohexanoate Chemical compound NCCCC[C@H](N)C(=O)OCC1=CC=CC=C1 XXAYGJGDVLSEML-LBPRGKRZSA-N 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- CEIWXEQZZZHLDM-AAEUAGOBSA-N (2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoic acid Chemical compound CCOC(=O)[C@@H](N[C@@H](C)C(O)=O)CCC1=CC=CC=C1 CEIWXEQZZZHLDM-AAEUAGOBSA-N 0.000 description 1
- YNLDFNVDZZGPHE-HOTGVXAUSA-N (2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]azaniumyl]-6-[(2,2,2-trifluoroacetyl)amino]hexanoate Chemical compound FC(F)(F)C(=O)NCCCC[C@@H](C(O)=O)N[C@H](C(=O)OCC)CCC1=CC=CC=C1 YNLDFNVDZZGPHE-HOTGVXAUSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- RRPZHYWZRCTYBG-UHFFFAOYSA-N 18,18-dimethylnonadecan-1-amine Chemical compound CC(C)(C)CCCCCCCCCCCCCCCCCN RRPZHYWZRCTYBG-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- DBOMTIHROGSFTI-UHFFFAOYSA-N 5-benzylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1CC1=CC=CC=C1 DBOMTIHROGSFTI-UHFFFAOYSA-N 0.000 description 1
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- VBQDSLGFSUGBBE-UHFFFAOYSA-N benzyl(triethyl)azanium Chemical compound CC[N+](CC)(CC)CC1=CC=CC=C1 VBQDSLGFSUGBBE-UHFFFAOYSA-N 0.000 description 1
- YOUGRGFIHBUKRS-UHFFFAOYSA-N benzyl(trimethyl)azanium Chemical compound C[N+](C)(C)CC1=CC=CC=C1 YOUGRGFIHBUKRS-UHFFFAOYSA-N 0.000 description 1
- WNBGYVXHFTYOBY-UHFFFAOYSA-N benzyl-dimethyl-tetradecylazanium Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 WNBGYVXHFTYOBY-UHFFFAOYSA-N 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- RKMJXTWHATWGNX-UHFFFAOYSA-N decyltrimethylammonium ion Chemical compound CCCCCCCCCC[N+](C)(C)C RKMJXTWHATWGNX-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- YOMFVLRTMZWACQ-UHFFFAOYSA-N ethyltrimethylammonium Chemical compound CC[N+](C)(C)C YOMFVLRTMZWACQ-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- 150000002668 lysine derivatives Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZUZLIXGTXQBUDC-UHFFFAOYSA-N methyltrioctylammonium Chemical compound CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC ZUZLIXGTXQBUDC-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- DIAIBWNEUYXDNL-UHFFFAOYSA-N n,n-dihexylhexan-1-amine Chemical compound CCCCCCN(CCCCCC)CCCCCC DIAIBWNEUYXDNL-UHFFFAOYSA-N 0.000 description 1
- OOHAUGDGCWURIT-UHFFFAOYSA-N n,n-dipentylpentan-1-amine Chemical compound CCCCCN(CCCCC)CCCCC OOHAUGDGCWURIT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- JACMPVXHEARCBO-UHFFFAOYSA-N n-pentylpentan-1-amine Chemical compound CCCCCNCCCCC JACMPVXHEARCBO-UHFFFAOYSA-N 0.000 description 1
- DYUWTXWIYMHBQS-UHFFFAOYSA-N n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCNCC=C DYUWTXWIYMHBQS-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- HTKPDYSCAPSXIR-UHFFFAOYSA-N octyltrimethylammonium ion Chemical compound CCCCCCCC[N+](C)(C)C HTKPDYSCAPSXIR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
- DTIFFPXSSXFQCJ-UHFFFAOYSA-N tetrahexylazanium Chemical compound CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC DTIFFPXSSXFQCJ-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- CHYBTAZWINMGHA-UHFFFAOYSA-N tetraoctylazanium Chemical compound CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC CHYBTAZWINMGHA-UHFFFAOYSA-N 0.000 description 1
- GJSGYPDDPQRWPK-UHFFFAOYSA-N tetrapentylammonium Chemical compound CCCCC[N+](CCCCC)(CCCCC)CCCCC GJSGYPDDPQRWPK-UHFFFAOYSA-N 0.000 description 1
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 description 1
- VPYJNCGUESNPMV-UHFFFAOYSA-N triallylamine Chemical compound C=CCN(CC=C)CC=C VPYJNCGUESNPMV-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- ZNEOHLHCKGUAEB-UHFFFAOYSA-N trimethylphenylammonium Chemical compound C[N+](C)(C)C1=CC=CC=C1 ZNEOHLHCKGUAEB-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
(産業上の利用分野)
本発明は、N2−(1−カルボキシ−3−フエニ
ルプロピル)−L−リジン誘導体、とりわけ下記
の光学活性なN2−(1−(S)−カルボキシ−3−
フエニルプロピル)−L−リジン誘導体()の
効率的な製造法に関するものであり、
〔式中、R1はアルキル基を表わし、R2はアシ
ル型保護基を表わす。星印(*)は不斉炭素につ
いて(S)配置を表わす。〕
優れたアンジオテンシン変換酵素(ACE)阻
害活性のため、抗高血圧剤としての利用が期待さ
れているN2−(1−(S)−エトキシカルボニル−
3−フエニルプロピル)−L−リジル−L−プロ
リン()
〔式中、星印(*)は不斉炭素について(S)
配置を示す〕の製造中間体として極めて有用な
N2−(1−(S)−カルボキシ−3−フエニルプロ
ピル)−L−リジン誘導体を工業的に有利に製造
することを目的とする。
(従来の技術)
N2−(1−カルボキシ−3−フエニルプロピ
ル)−L−リジン誘導体の製造法としては、既に
次式に示す如く、β−ベンゾイルアクリル酸エチ
ル()とL−リジンエステル誘導体(N6−ベ
ンジルオキシカルボニル−L−リジンベンジルエ
ステル())とを触媒量のトリエチルアミン存
在下、いわゆるマイケル(Michael)付加反応せ
しめ、ジアステレオマー混合物であるN2−(1−
エトキシカルボニル−3−オキソ−3−フエニル
プロピル)−N6−ベンジルオキシカルボニル−L
−リジンベンジルエステル()とした後、結晶
化操作によつて目的とする立体配置を有するN2
−(1−(S)−エトキシカルボニル−3−オキソ
−3−フエニルプロピル)−N6−ベンジルオキシ
カルボニル−L−リジンベンジルエステル(−
a)を得、更にこれをパラジウム炭素を触媒とし
た接触還元に付してN2−(1−(S)−エトキシカ
ルボニル−3−フエニルプロピル)−L−リジン
()とした後、リジン側鎖のアミノ基を保護す
るためにクロロ蟻酸ベンジルエステルと反応せし
め、生成物をシリカゲルクロマトグラフイーによ
り精製してN2−(1−(S)−エトキシカルボニル
−3−フエニルプロピル)−N6−ベンジルオキシ
カルボニル−L−リジン()を得る方法(特開
昭58−103364)が知られている。
(発明が解決しようとする題題点)
しかしながら、このL−リジンエステル誘導体
を用いる方法では、L−リジン誘導体のエステル
化操作に加え、エステル化時に使用した酸と塩を
形成したN6−ベンジルオキシカルボニル−L−
リジンベンジルエステルのα−アミノ基部分を遊
離化させる操作が必要であり、更にこのエステル
部分は最終的にβ−ベンゾイルアクリル酸エチル
に由来するエチルエステル部分を安定に保ちつつ
選択的に除去可能な基でなければならないため、
自ずからベンジルエステルもしくはtert−ブチル
エステルなど比較的調製に手間どるエステルに限
定される。また、リジンは側鎖にアミノ基を有す
る塩基性アミノ酸であるため、α位のアミノ基の
み反応せしめるためには、ε位のアミノ基は通常
ペプチド合成に利用される保護基により保護して
おくことが好ましいが、保護基としてベンジルオ
キシカルボニル基を用いると、(−a)から
()への還元反応の際に水素化分解されて脱離
する。()を更なる反応に供するためには、リ
ジン残基のεアミノ基部分を保護することが好ま
しいため、再びクロロ蟻酸ベンジルエステルを用
いてベンジルオキシカルボニル基の導入を実施し
ているが、()はリジン残基のε−アミノ基の
他、α−アミノ基も反応性を有するため副生成物
の生成は避け難い。そのためシリカゲルカラムで
精製して得られる()の()に対するモル収
率は42%と低調であり、N6−ベンジルオキシカ
ルボニル−L−リジンベンジルエステルからの総
合収率も15.8%と、加工度の高い原料を使用する
にもかかわらず低収率であり、N2−(1−カルボ
キシ−3−フエニルプロピル)−L−リジン誘導
体の工業的製造法としては操作性および経済性に
おいて種々の難点を有している。
(問題を解決するための手段及び作用効果)
本発明者らは先に、多くのアンジオテンシン変
換酵素阻害剤(ACEI)に共通の製造中間体とし
て極めて有用なN−(1−(S)−エトキシカルボ
ニル−3−オキソ−3−フエニルプロピル)−L
−アラニン及びN−(1−(S)−エトキシカルボ
ニル−3−フエニルプロピル)−L−アラニンを
経済的かつ効率的に製造する方法を(特開昭61−
178954号)、各種ACEIの合成に効率的に利用す
るための反応性誘導体として、N−(1−(S)−
エトキシカルボニル−3−フエニルプロピル)−
L−アラニルクロリド・無機酸塩と、その効率的
な製造法(特開昭62−48655号)、またN−(1−
(S)−エトキシカルボニル−3−フエニルプロピ
ル)−L−アラニンを利用して、ACEIの1つで
優れた効果が期待されているN−(1−(S)−エ
トキシカルボニル−3−フエニルプロピル)−L
−アラニル−L−プロリン(エナラプリル)を経
済的かつ効率的に製造する方法(特開昭62−
48696号)を特許出願した。本発明者らは、これ
ら技術を背景にアンジオテンシン変換酵素阻害剤
として極めて優れた薬効が期待されているN2−
(1−(S)−カルボキシ−3−フエニルプロピル)
−L−リジル−L−プロリン(リジノプリル)の
合成中間体として極めて有用なN2−(1−(S)−
カルボキシ−3−オキソ−3−フエニルプロピ
ル)−L−リジン誘導体()及びこれを還元し
てなるN2−(1−(S)−カルボキシ−3−フエニ
ルプロピル)−L−リジン誘導体()の簡便か
つ経済性にすぐれ、効率的な工業的製造法を確立
すべく検討を重ねた結果、一般式()
〔式中、R1はアルキル基を表わす〕で示され
るβ−ベンゾイルアクリル酸誘導体と、一般式
()
〔式中、R2はアシル型保護基を表わす〕で示
されるL−リジン誘導体とを、L−リジン誘導体
と当量の塩基を加えて反応させることにより、極
めて高収率にN2−(1−カルボキシ−3−オキソ
−3−フエニルプロピル)−L−リジン誘導体
()が得られること、さらに特定の制御された
反応条件下で反応を行なうことにより新たに生成
する不斉炭素の立体配置は、目的とする(S)配
置を不用の(R)配置に比較して極めて優先的に
生成させうることを見い出すと共に、生成物であ
るN2−(1−カルボキシ−3−オキソ−3−フエ
ニルプロピル)−L−リジン誘導体を接触水素化
分解することにより容易にN2−(1−カルボキシ
−3−フエニルプロピル)−L−リジン誘導体
()を製造できることを明らかにし、本発明を
完成するに至つた。本発明を式で示すと下記のよ
うになる。
〔R1およびR2は前記と同じ基を表わす〕
以下に本発明を詳細に説明する。
本発明の出発物質の1つであるβ−ベンゾイル
アクリル酸誘導体にはトランス体とシス体が存在
するが、トランス体はベンゼンと無水マレイン酸
のフリーデルクラフツアシル化反応、或いはグリ
オキシル酸とアセトフエノンの脱水縮合といた公
知の方法により得られるtrans−β−ベンゾイル
アクリル酸をエステル化するなどして容易に得ら
れる。またシス体はトランス体を光照射により異
性化して調製することができる。トランス体及び
シス体いずれの異性体も本発明の付加反応に利用
されるが、工業的利用の面からは加工度の低いト
ランス体が好ましい。
R1は、接触水素化分解に安定なアルキル基が、
3−オキソ基の接触水素化分解の際にも脱離しな
いので化合物()を更に反応に供する際にはと
くに有利である。これらの基としてはメチル基,
エチル基,n−プロピル基,iso−プロピル基,
n−ブチル基,tert−ブチル基などのC1〜C4程度
のアルキル基が使用できる。ベンジル基,ニトロ
ベンジル基,メトキシベンジル基は接触水素化分
解で脱離するので、この目的にはそぐわない。
もう一つの原料であるL−リジン誘導体はL−
リジンのα位とε位に2個のアミノ基を有するた
め、アミノ基を保護しないで付加反応に使用する
と反応は進行するが、α位のアミノ基が付加反応
した目的物の他にε位のアミノ基が反応した副生
成物が多量生成し、目的化合物の割合は50%程に
なる。従つてα位のアミノ基のみ反応せしめるに
は、ε位のアミノ基は通常ペプチド合成に利用さ
れる保護基により保護しておくことが好ましい。
N−保護基としては、トリフルオロアセチル
基、フオルミル基、フタロイル基といつたアシル
型保護基が接触水素化分解に対して安定で、接触
水素化分解の際にも脱離しないので、化合物
()を更に反応に供する場合、有利である。
εアミノ基を保護したリジンは、他の中性アミ
ノ酸と同様に両性イオンとして存在し、α−アミ
ノ基はプロトン化されているため求核性を有さ
ず、そのままではβ−ベンゾイルアクリル酸に対
して反応性を示さない。一般に両性イオンとして
存在する中性アミノ酸は溶液のPHによつて下記の
ようにイオン化の状態が変化することが知られて
いる。
H3N+−CH(R)−COOH−H+(pK′a1)
―――――――――→
←―――――――――
+H+
H3N+−CH(R)−COO-
−H+(pK′a2)
―――――――――→
H2N−CH(R)−COO-
〔Rはアミノ酸の側鎖を表わす〕
ε−アミノ基を保護したリジンは、塩基を添加
することによりアニオン化し、アミン成分として
働くようになる。すなわち、この場合実質的に反
応しうるのは、ε−アミノ基を保護したリジンと
塩基との塩であると考えられる。塩基の使用量と
しては、ε−アミノ基を保護したリジンに対し化
学量論的に当量用いることが好ましい。
反応に供する塩基としてはアルカリ金属水酸化
物、アルカリ土類金属水酸化物、アルカリ金属炭
酸塩、四級アンモニウム水酸化物、アミンまたは
アンモニアが挙げられる。四級アンモニウム水酸
化物としてはテトラメチルアンモニウム、テトラ
エチルアンモニウム、テトラプロピルアンモニウ
ム、テトラブチルアンモニウム、テトラアミルア
ンモニウム、テトラヘキシルアンモニウム、テト
ラオクチルアンモニウム、ベンジルトリメチルア
ンモニウム、ベンジルトリエチルアンモニウム、
セチルトリメチルアンモニウム、デシルトリメチ
ルアンモニウム、エチルトリメチルアンモニウ
ム、オクチルトリメチルアンモニウム、フエニル
トリメチルアンモニウム、トリメチルステアリル
アンモニウム、β−ヒドロキシエチルトリメチル
アンモニウム、トリオクチルメチルアンモニウ
ム、テトラデシルジメチルベンジルアンモニウム
などが、アミンとしてはメチルアミン、エチルア
ミン、プロピルアミン、ブチルアミン、アミルア
ミン、ヘキシルアミン、シクロヘキシルアミン、
ヘプチルアミン、オクチルアミン、アリルアミ
ン、α−フエニルエチルアミン、β−フエニルエ
チルアミンなどの一級アミン;ジメチルアミン、
ジエチルアミン、ジプロピルアミン、ジブチルア
ミン、ジアミルアミン、ジヘキシルアミン、ジシ
クロヘキシルアミン、ジアリルアミン、モルホリ
ン、ピペリジン、ヘキサメチレンイミンなどの二
級アミン;トリメチルアミン、トリエチルアミ
ン、トリプロピルアミン、トリブチルアミン、ト
リアミルアミン、トリヘキシルアミン、トリアリ
ルアミン、トリエタノールアミン、N−メチルモ
ルホリン、N,N−ジメチル−シクロヘキシルア
ミン、N,N,N′,N′−テトラメチルエチレン
ジアミン、4−ジメチルアミノピリジンなどの三
級アミンが挙げられる。
リジンのε−アミノ基の保護基がこれら塩基に
対して安定である場合は、予めこれら塩基とε−
アミノ基を保護したリジンとを、水またはアルコ
ール類を溶媒として室温或いは加温下撹拌すると
いつた簡便な操作で塩とした後、ベンゾイルアク
リル酸誘導体と反応させることが可能である。ま
た、ベンゾイルアクリル酸誘導体とε−アミノ基
を保護したリジンの混合物中に、これら塩基を化
学量論的必要量添加して、反応系において、
insituに塩を形成させながらマイルドに反応させ
ることも可能である。
β−ベンゾイルアクリル酸誘導体とε−アミノ
基を保護したリジンとを、塩基を使用して反応さ
せるマイケル付加反応の反応溶媒としては水ある
いはメタノール,エタノール,プロパノール,ブ
タノールなどのアルコール類、ジオキサン,テト
ラヒドロフランなどのエーテル類の他、n−ヘキ
サン,アセトニトリルなど、またはこれらの混合
溶媒を使用することができるが、通常はアルコー
ル−水系溶媒を用いるのが適当である。反応はア
ルコール−水系溶媒を用いた場合極めてすみやか
に進行し、通常室温下数分ないし1時間内に完結
する。
β−ベンゾイルアクリル酸誘導体とL−リジン
誘導体とのマイケル付加反応において、目的とす
る(S,S)配置のN2−(1−(S)−カルボキシ
−3−フエニルプロピル)−L−リジン誘導体の
生成率を選択的に高める好ましい条件は、反応試
剤の組み合せにより異なるが、大きく影響を及ぼ
す要因としては、反応温度、PH、L−リジン誘導
体のε−アミノ基の保護基の種類及び使用する塩
基の種類が挙げられる。反応温度は特に限定され
ず広範囲で行なえるが、生成するN2−(1−カル
ボキシ−3−オキソ−3−フエニルプロピル)−
L−リジン誘導体を反応系のようなアルカリ条件
下に放置すると、経時的な生成物の減少あるいは
ジアステレオマー間の組成比の変化が認められる
場合がある。ジアステレオマー間の組成比の変化
は反応中にも充分起こり得るため、(S,S)配
置の()の生成率を維持するためには通常反応
温度を25℃以下、とりわけ15℃以下にするのが好
ましい。しかし反応終了後、使用したアルカリ、
四級アンモニウムあるいは弱塩基に対し当量以上
の酸、特に塩酸、硫酸のような鉱酸を加えて系を
酸性化すると生成物の変化は認められなくなり安
定し、その後の操作が容易となる。
N2−(1−カルボキシ−3−オキソ−3−フエ
ニルプロピル)−L−リジン誘導体の単離は、常
法どおり、アルカリを酸で中和後、溶媒を減圧溜
去することによつて容易になし得るが、必要とあ
らば中和後、溶媒を減圧溜去して溶剤により抽出
して単離することも可能である。また、その塩酸
塩や硫酸塩として単離することも可能である。さ
らに単離しないでそのまま還元作用に移り、N2
−(1−カルボキシ−3−フエニルプロピル)−L
−リジン誘導体として単離することも可能であ
る。
具体的な例として、trans−β−ベンゾイルア
クリル酸エチルとε−トリフルオロアセチル−L
−リジンをエタノール−水系で反応させる場合、
アルカリ金属水酸化物、アルカリ土類金属水酸化
物としては水酸化リチウム、水酸化ナトリウム、
水酸化カリウムが適しており、とりわけ水酸化リ
チウムを使用すると(S,S)体/(R,S)体
=82/18という極めて高い選択性で目的とする
(S,S)体のN−(1−(S)−エトキシカルボニ
ル−3−オキソ−3−フエニルプロピル)−N6−
トリフルオロアセチル−L−リジンを得ることが
できる。また反応温度は10℃以下にするとジアス
テレオマー間の組成比の変化はほとんど認められ
ない。
付加反応後は、反応系に速やかに塩酸、硫酸な
どの酸を加え、生成したN2−(1−エトキシカル
ボニル−3−フエニルプロピル)−N6−トリフル
オロアセチル−L−リジンのアルカリ塩をN2−
(1−エトキシカルボニル−3−フエニルプロピ
ル)−N6−トリフルオロアセチル−L−リジンあ
るいはその塩酸塩、硫酸塩に変換し、常法により
安定的に単離できる。また、反応液に使用したア
ルカリに対して当量以上の塩酸または硫酸を加
え、N2−(1−エトキシカルボニル−3−オキソ
−3−フエニルプロピル)−N6−トリフルオロア
セチル−L−リジンとして単離することなく、次
の還元操作を連続的に実施することもできる。
N2−(1−カルボキシ−3−オキソ−3−フエ
ニルプロピル)−L−リジン誘導体のN2−(1−
カルボキシ−3−フエニルプロピル)−L−リジ
ン誘導体への接触水素化分解は、適当量の酸(硫
酸,塩酸,ギ酸など)の存在下、例えば水,アル
コール類、酢酸のような極性のプロトン性溶媒
中、穏やかに収率よく進行する。適当な触媒とし
てはパラジウム、ラネーニツケル等が挙げられ
る。N2−(1−エトキシカルボニル−3−オキソ
−3−フエニル)−N6−トリフルオロアセチル−
L−リジンの場合、エタノール等のアルコールを
溶媒とし、酸の存在下、触媒としてパラジウムカ
ーボンを適当量加え、0℃〜60℃、好ましくは5
℃〜40℃で水素添加し、数時間〜24時間反応させ
ることによりほぼ定量的にN2−(1−カルボキシ
−3−フエニルプロピル)−N6−トリフルオロア
セチル−L−リジンに変換することができる。還
元反応終了後は、触媒を分離後、アルカリで酸を
中和し、溶媒を除去後、抽出等の操作により容易
に単離することが可能であり、必要であれば再結
晶操作により目的とする(S,S)配置の化合物
を得ることも可能である。
以上のようにして得られるN2−(1−カルボキ
シ−3−フエニルプロピル)−L−リジン誘導体
とりわけN2−(1−(S)−カルボキシ−3−フエ
ニルプロピル)−L−リジン誘導体は、酸クロリ
ド法、NCA法、活性エステル法、混合酸無水物
法など通常ペプチド合成に用いられる公知の方法
により容易にリジノプリル誘導体へと導くことが
可能である。
(発明の効果)
以上の説明で明らかな如く、本発明は抗高血圧
剤としてその将来性が注目されているN2−(1−
(S)−カルボキシ−3−フエニルプロピル)−L
−リジル−L−プロリン(リジノプリル)の合成
中間体として極めて有用なN2−(1−カルボキシ
−3−オキソ−3−フエニルプロピル)−L−リ
ジン誘導体、とりわけその光学活性体であるN2
−(1−(S)−カルボキシ−3−オキソ−3−フ
エニルプロピル)−L−リジン誘導体及びこれら
を還元してなる化合物を安価にかつ高収率に与え
るものであり、リジノプリルの経済的かつ効率的
な工業的製造に極めて有利な方法を提供するもの
である。
(実施例)
以下に実施例を挙げて本発明を説明する。
定量分析は、高速液体クロマトグラフイー
(HPLC)によつて実施した。前記した如く、N2
−(1−カルボキシ−3−オキソ−3−フエニル
プロピル)−L−リジン誘導体はアルカリ性で若
干不安定で、(S,S)体は(R,S)体に熱力
学的に変換しやすいことから、被検液は充分酸性
化して組成変化を停止した後、分析に供した。ま
た分析には原則として下記条件を使用し、(S,
S)体、(R,S)体を完全に分離定量した。但
しN2−(1−カルボキシ−3−オキソ−3−フエ
ニルプロピル)−L−リジン誘導体の極性に応じ、
移動相の溶媒比は適宜調整して使用した。
カラム:Finepak SIL C18-5(日本分光(株)製)
4.6mmID×250mm
移動相:60mMリン酸緩衝液(PH2.5)/アセニ
トリル=75/25(v/v)
両 速:1.2ml/min
検 出:210nm
内部標準:5−ベンジルヒダントイン
実施例 1
trans−β−ベンゾイルアクリル酸エチル(以
下t−EBAとする)40.8mgをエタノール/水=
3/1の溶液2.0mlに溶解し、これにN6−トリフ
ルオロアセチル−L−リジン(以下L−Lys
(Tfa)とする)48.4mgを加えた懸濁液に表1に
示すアルカリ金属水酸化物(0.2mmole)または
アルカリ土類金属水酸化物(0.1mmole)を含む
水溶液あるいは懸濁液0.2ml、氷冷下、迅速に加
えて、そのまま30分間撹拌後、酸を添加して反応
を停止させて、HPLCにて生成物の分析を実施
し、以下に示すようなN2−(1−エトキシカルボ
ニル−3−オキソ−3−フエニルプロピル)−N6
−トリフルオロアセチル)−L−ジンの生成を認
めた。
(Industrial Application Field) The present invention relates to N 2 -(1-carboxy-3-phenylpropyl)-L-lysine derivatives, particularly the following optically active N 2 -(1-(S)-carboxy-3 −
(phenylpropyl)-L-lysine derivative (), [In the formula, R 1 represents an alkyl group, and R 2 represents an acyl-type protecting group. The asterisk (*) represents the (S) configuration for the asymmetric carbon. ] N2- (1-(S)-ethoxycarbonyl-) is expected to be used as an antihypertensive agent due to its excellent angiotensin-converting enzyme (ACE) inhibitory activity.
3-phenylpropyl)-L-lysyl-L-proline () [In the formula, the asterisk (*) represents an asymmetric carbon (S)
extremely useful as an intermediate for the production of
The object of the present invention is to industrially advantageously produce N2-(1-(S)-carboxy-3-phenylpropyl)-L-lysine derivatives. (Prior art) As a method for producing N 2 -(1-carboxy-3-phenylpropyl)-L-lysine derivative, as shown in the following formula, β-benzoylacrylate ethyl () and L-lysine ester are used. The derivative (N 6 -benzyloxycarbonyl-L-lysine benzyl ester ()) was subjected to a so-called Michael addition reaction in the presence of a catalytic amount of triethylamine to form a diastereomer mixture N 2 -(1-
Ethoxycarbonyl-3-oxo-3-phenylpropyl) -N6 -benzyloxycarbonyl-L
- After converting into lysine benzyl ester (), N2 having the desired configuration is subjected to a crystallization operation.
-(1-(S)-Ethoxycarbonyl-3-oxo-3-phenylpropyl)-N 6 -benzyloxycarbonyl-L-lysine benzyl ester (-
a) was obtained, which was further subjected to catalytic reduction using palladium carbon as a catalyst to give N2- (1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-lysine (), and then lysine The side chain amino group was protected by reaction with benzyl chloroformate, and the product was purified by silica gel chromatography to give N 2 -(1-(S)-ethoxycarbonyl-3-phenylpropyl)-N A method for obtaining 6 -benzyloxycarbonyl-L-lysine () is known (Japanese Unexamined Patent Publication No. 103364/1983). (Problem to be Solved by the Invention) However, in the method using this L-lysine ester derivative, in addition to the esterification operation of the L-lysine derivative, N 6 -benzyl which has formed a salt with the acid used during esterification is Oxycarbonyl-L-
It is necessary to perform an operation to liberate the α-amino group of lysine benzyl ester, and furthermore, this ester can be selectively removed while keeping the ethyl ester moiety derived from β-benzoyl ethyl acrylate stable. Because it must be based on
Naturally, it is limited to esters that are relatively difficult to prepare, such as benzyl esters and tert-butyl esters. In addition, since lysine is a basic amino acid with an amino group in its side chain, in order to react only with the amino group at the α position, the amino group at the ε position must be protected with a protecting group that is normally used in peptide synthesis. However, when a benzyloxycarbonyl group is used as a protecting group, it is hydrogenolyzed and eliminated during the reduction reaction from (-a) to (). In order to subject () to further reaction, it is preferable to protect the ε-amino group of the lysine residue, so benzyloxycarbonyl group was introduced using benzyl chloroformate again. ) has reactivity not only in the ε-amino group but also in the α-amino group of the lysine residue, so the generation of by-products is unavoidable. Therefore, the molar yield of () obtained by purification with a silica gel column relative to () is low at 42%, and the overall yield from N 6 -benzyloxycarbonyl-L-lysine benzyl ester is 15.8%, indicating a high degree of processing. The yield is low despite using high-quality raw materials, and there are various methods for producing N 2 -(1-carboxy-3-phenylpropyl)-L-lysine derivatives in terms of operability and economy. It has its drawbacks. (Means and Effects for Solving the Problem) The present inventors have previously discovered that N-(1-(S)-ethoxy carbonyl-3-oxo-3-phenylpropyl)-L
-A method for economically and efficiently producing alanine and N-(1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine
178954), N-(1-(S)-
ethoxycarbonyl-3-phenylpropyl)-
L-alanyl chloride inorganic acid salt and its efficient production method (JP-A-62-48655), and N-(1-
Using (S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine, N-(1-(S)-ethoxycarbonyl-3-phenylpropyl), which is one of the ACEIs and is expected to have excellent effects. enylpropyl)-L
- Method for economically and efficiently producing alanyl-L-proline (enalapril) (JP-A-62-
No. 48696) was applied for a patent. Based on these technologies, the present inventors have discovered that N2-
(1-(S)-carboxy-3-phenylpropyl)
-N2- (1-(S)-) which is extremely useful as a synthetic intermediate for -L-lysyl-L-proline (lisinopril)
Carboxy-3-oxo-3-phenylpropyl)-L-lysine derivative () and N2-( 1- (S)-carboxy-3-phenylpropyl)-L-lysine derivative obtained by reducing it ( ) As a result of repeated studies to establish a simple, economical, and efficient industrial manufacturing method, the general formula () was developed. A β-benzoyl acrylic acid derivative represented by [wherein R 1 represents an alkyl group] and the general formula () By reacting the L-lysine derivative represented by the formula [wherein R 2 represents an acyl-type protecting group] with an equivalent amount of base, N 2 -(1 -Carboxy-3-oxo-3-phenylpropyl)-L-lysine derivative () is obtained, and the configuration of the asymmetric carbon newly generated by carrying out the reaction under specific controlled reaction conditions. found that the desired (S) configuration can be produced with high priority over the unwanted (R) configuration, and the product N 2 -(1-carboxy-3-oxo-3- It was revealed that N 2 -(1-carboxy-3-phenylpropyl)-L-lysine derivative ( ) can be easily produced by catalytic hydrogenolysis of L-lysine derivative (phenylpropyl)-L-lysine, and the present invention was achieved by It was completed. The present invention can be expressed by the following formula. [R 1 and R 2 represent the same groups as above] The present invention will be explained in detail below. The β-benzoyl acrylic acid derivative, which is one of the starting materials of the present invention, exists in trans and cis forms. It can be easily obtained by esterifying trans-β-benzoyl acrylic acid obtained by a known method such as dehydration condensation. Moreover, the cis form can be prepared by isomerizing the trans form by light irradiation. Both the trans isomer and the cis isomer can be used in the addition reaction of the present invention, but the trans isomer, which is less processed, is preferred from the standpoint of industrial use. R 1 is an alkyl group stable to catalytic hydrogenolysis,
Since the 3-oxo group is not eliminated during catalytic hydrogenolysis, it is particularly advantageous when compound () is further subjected to a reaction. These groups include methyl group,
Ethyl group, n-propyl group, iso-propyl group,
C1 to C4 alkyl groups such as n-butyl group and tert-butyl group can be used. Benzyl, nitrobenzyl, and methoxybenzyl groups are eliminated by catalytic hydrogenolysis, so they are not suitable for this purpose. Another raw material, L-lysine derivative, is L-
Lysine has two amino groups at the α-position and the ε-position, so if it is used in the addition reaction without protecting the amino group, the reaction will proceed, but the amino group at the α-position will be added to the target product at the ε-position. A large amount of by-products are produced by the reaction of the amino groups of the target compound, and the proportion of the target compound is about 50%. Therefore, in order to react only the amino group at the α-position, it is preferable to protect the amino group at the ε-position with a protecting group commonly used in peptide synthesis. As N-protecting groups, acyl-type protecting groups such as trifluoroacetyl, formyl, and phthaloyl groups are stable against catalytic hydrogenolysis and do not leave off during catalytic hydrogenolysis; ) is advantageously subjected to further reaction. Lysine with a protected ε-amino group exists as a zwitterion like other neutral amino acids, and since the α-amino group is protonated, it does not have nucleophilic properties, and as it is, it cannot be converted into β-benzoyl acrylic acid. shows no reactivity against It is known that the ionization state of neutral amino acids, which generally exist as zwitterions, changes depending on the pH of the solution as shown below. H 3 N + −CH(R)−COOH−H + (pK′a 1 ) ―――――――――→ ←―――――――――― +H + H 3 N + −CH(R )−COO - −H + (pK′a 2 ) ―――――――――→ H 2 N−CH(R)−COO - [R represents the side chain of the amino acid] ε-Protects the amino group The resulting lysine is anionized by adding a base and comes to function as an amine component. That is, it is thought that what can substantially react in this case is a salt of lysine with a protected ε-amino group and a base. The amount of base to be used is preferably stoichiometrically equivalent to lysine with a protected ε-amino group. Examples of the base used in the reaction include alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal carbonates, quaternary ammonium hydroxides, amines, and ammonia. Quaternary ammonium hydroxides include tetramethylammonium, tetraethylammonium, tetrapropylammonium, tetrabutylammonium, tetraamylammonium, tetrahexylammonium, tetraoctylammonium, benzyltrimethylammonium, benzyltriethylammonium,
Cetyltrimethylammonium, decyltrimethylammonium, ethyltrimethylammonium, octyltrimethylammonium, phenyltrimethylammonium, trimethylstearylammonium, β-hydroxyethyltrimethylammonium, trioctylmethylammonium, tetradecyldimethylbenzylammonium, etc., and examples of amines include methylamine , ethylamine, propylamine, butylamine, amylamine, hexylamine, cyclohexylamine,
Primary amines such as heptylamine, octylamine, allylamine, α-phenylethylamine, β-phenylethylamine; dimethylamine,
Secondary amines such as diethylamine, dipropylamine, dibutylamine, diamylamine, dihexylamine, dicyclohexylamine, diallylamine, morpholine, piperidine, hexamethyleneimine; trimethylamine, triethylamine, tripropylamine, tributylamine, triamylamine, trihexylamine , triallylamine, triethanolamine, N-methylmorpholine, N,N-dimethyl-cyclohexylamine, N,N,N',N'-tetramethylethylenediamine, and 4-dimethylaminopyridine. If the protecting group for the ε-amino group of lysine is stable against these bases,
It is possible to convert lysine with a protected amino group into a salt by a simple operation such as stirring in water or an alcohol as a solvent at room temperature or with heating, and then react it with a benzoyl acrylic acid derivative. In addition, a stoichiometric amount of these bases is added to a mixture of a benzoyl acrylic acid derivative and a lysine with a protected ε-amino group, and in the reaction system,
It is also possible to carry out a mild reaction while forming a salt in situ. The reaction solvent for the Michael addition reaction, in which a β-benzoyl acrylic acid derivative and lysine with a protected ε-amino group are reacted using a base, is water, alcohols such as methanol, ethanol, propanol, butanol, dioxane, and tetrahydrofuran. In addition to ethers such as n-hexane, acetonitrile, etc., or a mixed solvent thereof can be used, but it is usually appropriate to use an alcohol-water solvent. The reaction proceeds very quickly when an alcohol-water solvent is used, and is usually completed within several minutes to one hour at room temperature. In the Michael addition reaction between a β-benzoyl acrylic acid derivative and an L-lysine derivative, N 2 -(1-(S)-carboxy-3-phenylpropyl)-L-lysine with the desired (S,S) configuration is Preferred conditions for selectively increasing the production rate of derivatives vary depending on the combination of reaction reagents, but factors that have a major influence include reaction temperature, pH, and the type and use of the protective group for the ε-amino group of the L-lysine derivative. Examples include the types of bases that can be used. The reaction temperature is not particularly limited and can be carried out over a wide range, but the N2- (1-carboxy-3-oxo-3-phenylpropyl)-
When an L-lysine derivative is left under alkaline conditions such as in a reaction system, a decrease in the amount of the product over time or a change in the composition ratio between diastereomers may be observed. Changes in the composition ratio between diastereomers can easily occur during the reaction, so in order to maintain the production rate of () with the (S,S) configuration, the reaction temperature is usually kept below 25°C, especially below 15°C. It is preferable to do so. However, after the reaction is complete, the alkali used
When the system is acidified by adding an equivalent amount or more of an acid, especially a mineral acid such as hydrochloric acid or sulfuric acid, to the quaternary ammonium or weak base, no change in the product is observed and it becomes stable, making subsequent operations easier. The N 2 -(1-carboxy-3-oxo-3-phenylpropyl)-L-lysine derivative is isolated by neutralizing the alkali with an acid and then distilling the solvent off under reduced pressure in the usual manner. Although this can be easily done, if necessary, it is also possible to isolate by neutralizing, distilling off the solvent under reduced pressure, and extracting with a solvent. It is also possible to isolate it as its hydrochloride or sulfate. Without further isolation, the N 2
-(1-carboxy-3-phenylpropyl)-L
-It is also possible to isolate it as a lysine derivative. As a specific example, trans-β-ethyl benzoylacrylate and ε-trifluoroacetyl-L
- When reacting lysine in an ethanol-water system,
Alkali metal hydroxides and alkaline earth metal hydroxides include lithium hydroxide, sodium hydroxide,
Potassium hydroxide is suitable, and especially when lithium hydroxide is used, the target N- (1-(S)-ethoxycarbonyl-3-oxo-3-phenylpropyl)-N 6 -
Trifluoroacetyl-L-lysine can be obtained. Further, when the reaction temperature is set to 10°C or less, almost no change in the composition ratio between diastereomers is observed. After the addition reaction, an acid such as hydrochloric acid or sulfuric acid is immediately added to the reaction system to form an alkali salt of N 2 -(1-ethoxycarbonyl-3-phenylpropyl)-N 6 -trifluoroacetyl-L-lysine. N 2 −
It can be converted into (1-ethoxycarbonyl-3-phenylpropyl)-N 6 -trifluoroacetyl-L-lysine or its hydrochloride or sulfate and stably isolated by a conventional method. In addition, an equivalent amount or more of hydrochloric acid or sulfuric acid is added to the alkali used in the reaction solution, and N 2 -(1-ethoxycarbonyl-3-oxo-3-phenylpropyl)-N 6 -trifluoroacetyl-L-lysine is added. The following reduction operation can also be carried out continuously without isolating the product. N 2 -(1 - carboxy-3-oxo-3-phenylpropyl)-L-lysine derivative
Catalytic hydrogenolysis to carboxy-3-phenylpropyl)-L-lysine derivatives is carried out in the presence of an appropriate amount of acid (sulfuric acid, hydrochloric acid, formic acid, etc.), e.g., water, alcohols, polar protons such as acetic acid, etc. The process proceeds slowly and with good yield in a neutral solvent. Suitable catalysts include palladium, Raney nickel, and the like. N 2 -(1-ethoxycarbonyl-3-oxo-3-phenyl)-N 6 -trifluoroacetyl-
In the case of L-lysine, use alcohol such as ethanol as a solvent, add an appropriate amount of palladium carbon as a catalyst in the presence of an acid, and heat at 0°C to 60°C, preferably 5°C.
By hydrogenating at ℃ to 40℃ and reacting for several hours to 24 hours, it is almost quantitatively converted to N 2 -(1-carboxy-3-phenylpropyl)-N 6 -trifluoroacetyl-L-lysine. be able to. After the reduction reaction is completed, it is possible to easily isolate the catalyst by separating the catalyst, neutralizing the acid with an alkali, removing the solvent, and performing operations such as extraction.If necessary, the desired product can be isolated by recrystallization. It is also possible to obtain compounds with the (S,S) configuration. N2- (1-carboxy-3-phenylpropyl)-L-lysine derivatives obtained as above, especially N2- (1-(S)-carboxy-3-phenylpropyl)-L-lysine derivatives can be easily converted into lisinopril derivatives by known methods commonly used for peptide synthesis, such as the acid chloride method, NCA method, active ester method, and mixed acid anhydride method. (Effects of the Invention) As is clear from the above explanation, the present invention provides N2- (1-
(S)-carboxy-3-phenylpropyl)-L
-N2- (1-carboxy-3-oxo-3-phenylpropyl)-L-lysine derivatives, which are extremely useful as intermediates for the synthesis of lysyl-L-proline (lisinopril), especially its optically active form N2
-(1-(S)-carboxy-3-oxo-3-phenylpropyl)-L-lysine derivatives and compounds obtained by reducing them at low cost and in high yield, and are economical for lisinopril. Moreover, it provides an extremely advantageous method for efficient industrial production. (Example) The present invention will be described below with reference to Examples. Quantitative analysis was performed by high performance liquid chromatography (HPLC). As mentioned above, N 2
-(1-Carboxy-3-oxo-3-phenylpropyl)-L-lysine derivatives are slightly unstable in alkaline conditions, and the (S,S) form is easily converted to the (R,S) form thermodynamically. Therefore, the test solution was subjected to analysis after being sufficiently acidified to stop the composition change. In principle, the following conditions are used for analysis: (S,
The S) and (R,S) bodies were completely separated and quantified. However, depending on the polarity of the N 2 -(1-carboxy-3-oxo-3-phenylpropyl)-L-lysine derivative,
The solvent ratio of the mobile phase was adjusted appropriately. Column: Finepak SIL C 18-5 (manufactured by JASCO Corporation) 4.6mm ID x 250mm Mobile phase: 60mM phosphate buffer (PH2.5)/acenitrile = 75/25 (v/v) Both speeds: 1.2ml/ min Detection: 210 nm Internal standard: 5-benzylhydantoin Example 1 40.8 mg of trans-β-benzoylacrylate ethyl acrylate (hereinafter referred to as t-EBA) was mixed with ethanol/water =
Dissolve in 2.0 ml of 3/1 solution and add N 6 -trifluoroacetyl-L-lysine (hereinafter L-Lys).
0.2 ml of an aqueous solution or suspension containing the alkali metal hydroxide (0.2 mmole) or alkaline earth metal hydroxide (0.1 mmole) shown in Table 1 to the suspension in which 48.4 mg (Tfa) was added; The reaction was quickly added under ice-cooling and stirred for 30 minutes, then an acid was added to stop the reaction, and the product was analyzed by HPLC. -3-oxo-3-phenylpropyl)-N 6
-Trifluoroacetyl)-L-zine was observed to be produced.
【表】
実施例 2
trans−β−ベンゾイルアクリル酸エチル(以
下、t−EBAとする)204.0mgとN6−トリフルオ
ロアセチル−L−リジン254.0mgと水−EtOH5.0
mlとからなる懸濁液に、表2に示す各種アミン
1.0mmoleを0℃においてマグネチツクスターラ
ーで撹拌しながら瞬時に添加し、そのまま60分間
撹拌後、酸を添加して反応を停止させて、HPLC
にて生成物の分析を実施し以下に示すようなN2
−(1−エトキシカルボニル−3−オキソ−3−
フエニルプロピル)−N6−トリフルオロアセチル
−L−リジンの生成を認めた。[Table] Example 2 204.0 mg of trans-β-ethyl benzoylacrylate (hereinafter referred to as t-EBA), 254.0 mg of N 6 -trifluoroacetyl-L-lysine, and 5.0 mg of water-EtOH
ml of various amines shown in Table 2.
Add 1.0 mmole instantly at 0°C while stirring with a magnetic stirrer, stir for 60 minutes, add acid to stop the reaction, and perform HPLC.
The product was analyzed using N 2 as shown below.
-(1-ethoxycarbonyl-3-oxo-3-
Formation of (phenylpropyl)-N 6 -trifluoroacetyl-L-lysine was observed.
【表】【table】
【表】
実施例 3
t−EBA40.8mgをエタノール/水=3/1の
溶液2.0mlに溶解し、これにL−Lys(Tfa)48.4mg
を加えた懸濁液に表3に示すアルカリ金属水酸化
物(0.2mmole)を含む水溶液0.2mlを氷冷下また
は20℃において迅速に加え、そのまま30分間撹拌
後、実施例1と同様に操作して生成物の分析を実
施し、以下に示すようなN2−(1−エトキシカル
ボニル−3−オキソ−3−フエニルプロピル)−
N6−トリフルオロアセチル−L−リジンの生成
を認めた。[Table] Example 3 40.8 mg of t-EBA was dissolved in 2.0 ml of a solution of ethanol/water = 3/1, and 48.4 mg of L-Lys (Tfa) was added to this.
0.2 ml of an aqueous solution containing the alkali metal hydroxide (0.2 mmole) shown in Table 3 was quickly added to the suspension under ice cooling or at 20°C, and after stirring for 30 minutes, the same procedure as in Example 1 was carried out. Analysis of the product was performed using N2- (1-ethoxycarbonyl-3-oxo-3-phenylpropyl)- as shown below.
Production of N 6 -trifluoroacetyl-L-lysine was observed.
【表】【table】
【表】
実施例 4
t−EBA2.45gをエタノール/水=3/1の
溶液50.0mlに溶解し、これにL−Lys(Tfa)2.42
gを加えて懸濁し、30℃に加温した。これに炭酸
カリウム2.45gを迅速に加え、そのまま撹拌を続
けた。20分後、反応液はほぼ均一となり、60分
後、濃塩酸1.67mlを加えて反応を停止しHPLCに
よる分析を実施してN2−(1−エトキシカルボニ
ル−3−オキソ−3−フエニルプロピル)−N6−
トリフルオロアセチル−L−リジン3.48gの生成
を認めた。また生成したジアステレオマーの比は
(S,S)体/(R,S)体=61.0/39.0であつ
た。次に、この反応液の溶媒を減圧溜去し、得ら
れた残渣にエタノール50mlを加え、氷冷下、撹拌
しながら2.5N−NaOH4.0mlを徐々に加えた後、
室温下、溶媒を減圧溜去した。残渣に酢エチを加
えて抽出し、過後、酢エチ抽出液を水洗し、硫
酸ナトリウムにて乾燥後、減圧濃縮し、これにエ
ーテル−n−ヘキサンを加えて結晶化させ、N2
−(1−エトキシカルボニル−3−オキソ−3−
フエニルプロピル)−N6−トリフルオロアセチル
−L−リジン3.08gを得た。〔(S,S)体/
(R,S)体=60.5/39.5〕。
実施例 5
t−EBA81.6gをエタノール/水=3/1の
溶液1.0に溶解し、これにL−Lys(Tfa)48.4g
を加えて懸濁し、氷冷して内温3℃迄冷却した。
これにN−LiOH水溶液200.0mlを撹拌下20分間で
滴下し、滴下終了後、さらに40分間撹拌を続け
た。濃塩酸33.3mlを添加して反応を停止し、
HPLCによる分析を実施し、N2−(1−エトキシ
カルボニル−3−オキソ−3−フエニルプロピ
ル)−N6−トリフルオロアセチル−L−リジン
84.9gの生成を認めた。〔(S,S)体/(R,
S)体=78.0/22.0〕。この反応液を実施例4と
同様に処理し、N2−(1−エトキシカルボニル−
3−オキソ−3−フエニルプロピル)−N6−トリ
フルオロアセチル−L−リジン75.8gを結晶とし
て得た。〔(S,S)体/(R,S)体=79.0/
21.0〕。
1H−NMR(90MHz,CDCl3+DMSO−d6):δ
(ppm);
1.15〜1.4(t,3H)、0.9〜1.9(m,6H)、3.0
〜3.55(m,5H)、3.6〜3.85(m,1H)、3.95
〜4.3(q,2H)、7.3〜8.1(m,5H)、8.13〜
8.53(m,1H)
IR(cm-1,KBr disk):3375,2950,1710,
1630,1600,1550,1210,1185,690
〔α〕25 D=+23.7゜(c=1.0、N−HC1)
実施例 6
t−EBA40.8gをエタノール500mlに溶解し、
これにL−Lys(Tfa)48.4gを加えて懸濁し、内
温を−5℃迄冷却した。これにN−LiOH水溶液
200.0mlを撹拌下150分間で連続添加し、添加終了
後、さらに30分間撹拌を続けた。内温は反応中−
5℃に保つた。これに濃塩酸33.3mlを添加して反
応を停止し、HPLCによる分析を実施し、N2−
(1−エトキシカルボニル−3−オキソ−3−フ
エニルプロピル)−N6−トリフルオロアセチル−
L−リジン81.4gの生成認めた。〔(S,S)体/
(R,S)体=82.1/17.9〕。この反応液を実施例
4と同様に処理し、N2−(1−エトキシカルボニ
ル−3−オキソ−3−フエニルプロピル)−N6−
トリフルオロアセチル−L−リジン65.0gを結晶
として得た。〔(S,S)体/(R,S)体=
81.9/18.1〕。
実施例 7
エタノール500mlに濃塩酸13.1mlを加え、これ
に実施例6で得たN2−(1−エトキシカルボニル
−3−オキソ−3−フエニルプロピル)−N6−ト
リフルオロアセチル−L−リジン35.0gを加えて
溶解し、これに10%パラジウムカーボン10.5gを
加えて40℃、常圧下で水素添加を実施した。反応
後、触媒を吸引過し、このエタノール溶液を水
酸化ナトリウムでPH4.5に調整した後、水を加え、
減圧濃縮してエタノールを溜去し、水に置換し
た。析出した白色結晶を過してN2−(1−エト
キシカルボニル−3−フエニルプロピル)−N6−
トリフルオロアセチル−L−リジン32.0gを得
た。〔(S,S)体/(R,S)体=81.9/18.1〕。
これを水−エタノールから再結晶してN2−(1−
(S)−エトキシカルボニル−3−フエニルプロピ
ル)−N6−トリフルオロアセチル−L−リジンを
得た。
1H−NMR(90MHz,CDCl3):δ(ppm);1.2〜
1.43
(t,3H)、1.42〜2.25(m,8H)、2.5〜2.85
(m,
2H)、3.0〜3.55(m,4H)、4.05〜4.35(q,
2H)、
6.9〜7.4(m,5H)
IR(cm-1,KBr disk)3320,1740,1700,
1615,1205,1170,750,700
mp 135.5〜137.0℃
〔α〕25 D=+7.8゜(c=2.0、EtOH)
実施例 8
t−EBA8.16gをエタノール100mlに溶解し、
これにL−Lys(Tfa)9.69gを加えて懸濁し、−
5℃に保ちながらN−LiOH水溶液20.0mlを撹拌
下150分間で連続添加した。添加終了後、さらに
30分間撹拌を続けた後、濃塩酸10.0mlを加えて反
応を停止した。これにエタノール130ml、10%パ
ラジウムカーボン5.0gを加えて40℃、常圧下で
水素添加を実施した。反応後、触媒を除去し、実
施例7と同様に処理してN2−(1−エトキシカル
ボニル−3−フエニルプロピル)−N6−トリフル
オロアセチル−L−リジン14.1gを得た。〔(S,
S)体/(R,S)体=82.0/18.0〕。
参考例
t−EBA4.08gをエタノール/水=10/1の
溶液50mlに溶解し、これにN6−ベンジルオキシ
カルボニル−L−リジン(L−Lys(z))5.0gを
加えて懸濁し、室温下、水酸化リチウム・1水塩
0.75gを瞬時に添加し、そのまま1時間撹拌を続
けた。反応終了後、濃塩酸5.94mlを加え、10%パ
ラジウムカーボン2.0gを加えて40℃、常圧下で
水素添加を実施した。反応後、触媒を除去し、水
酸化ナトリウムでPH8.9に調整後、溶媒を減圧溜
去し、残留物にエタノールを加えて抽出を行な
い、不溶物を過により除去した。液のPHを塩
酸で4.6に調整し、減圧濃縮して得られた残留物
をエーテルで結晶化させ、N2−(1−エトキシカ
ルボニル−3−フエニルプロピル)−L−リジ
ン・塩酸塩4.0gを得た。[Table] Example 4 2.45 g of t-EBA was dissolved in 50.0 ml of a solution of ethanol/water = 3/1, and 2.42 g of L-Lys (Tfa) was added to this.
g was added and suspended, and the mixture was heated to 30°C. 2.45 g of potassium carbonate was quickly added to this, and stirring was continued. After 20 minutes, the reaction solution became almost homogeneous, and after 60 minutes, 1.67 ml of concentrated hydrochloric acid was added to stop the reaction, and analysis by HPLC was performed. propyl) −N 6 −
Production of 3.48 g of trifluoroacetyl-L-lysine was observed. The ratio of the diastereomers produced was (S,S) form/(R,S) form = 61.0/39.0. Next, the solvent of this reaction solution was distilled off under reduced pressure, 50 ml of ethanol was added to the resulting residue, and 4.0 ml of 2.5N-NaOH was gradually added while stirring under ice cooling.
The solvent was distilled off under reduced pressure at room temperature. The residue was extracted by adding ethyl acetate, and after filtration, the ethyl acetate extract was washed with water, dried over sodium sulfate, concentrated under reduced pressure, and crystallized by adding ether- n -hexane to it.
-(1-ethoxycarbonyl-3-oxo-3-
3.08 g of (phenylpropyl) -N6 -trifluoroacetyl-L-lysine was obtained. [(S,S) body/
(R, S) body = 60.5/39.5]. Example 5 81.6 g of t-EBA was dissolved in a 1.0 solution of ethanol/water = 3/1, and 48.4 g of L-Lys (Tfa) was added to this.
was added and suspended, and the mixture was cooled on ice to an internal temperature of 3°C.
200.0 ml of N-LiOH aqueous solution was added dropwise to this solution over 20 minutes with stirring, and after the addition was completed, stirring was continued for an additional 40 minutes. The reaction was stopped by adding 33.3 ml of concentrated hydrochloric acid,
Analysis by HPLC was performed and N2- (1-ethoxycarbonyl-3-oxo-3-phenylpropyl) -N6 -trifluoroacetyl-L-lysine
Production of 84.9g was observed. [(S,S) body/(R,
S) Body = 78.0/22.0]. This reaction solution was treated in the same manner as in Example 4, and N 2 -(1-ethoxycarbonyl-
75.8 g of 3-oxo-3-phenylpropyl)-N 6 -trifluoroacetyl-L-lysine was obtained as crystals. [(S,S) body/(R,S) body=79.0/
21.0〕. 1H −NMR (90MHz, CDCl 3 +DMSO−d 6 ): δ
(ppm); 1.15-1.4 (t, 3H), 0.9-1.9 (m, 6H), 3.0
~3.55 (m, 5H), 3.6 ~ 3.85 (m, 1H), 3.95
~4.3 (q, 2H), 7.3~8.1 (m, 5H), 8.13~
8.53 (m, 1H) IR (cm -1 , KBr disk): 3375, 2950, 1710, 1630, 1600, 1550, 1210, 1185, 690 [α] 25 D = +23.7° (c = 1.0, N- HC1) Example 6 40.8g of t-EBA was dissolved in 500ml of ethanol,
48.4 g of L-Lys (Tfa) was added to this and suspended, and the internal temperature was cooled to -5°C. Add N-LiOH aqueous solution to this
200.0 ml was continuously added over 150 minutes with stirring, and after the addition was complete, stirring was continued for an additional 30 minutes. Internal temperature is during reaction-
It was kept at 5°C. The reaction was stopped by adding 33.3 ml of concentrated hydrochloric acid, and analysis by HPLC was performed.
(1-ethoxycarbonyl-3-oxo-3-phenylpropyl) -N6 -trifluoroacetyl-
Production of 81.4 g of L-lysine was observed. [(S,S) body/
(R, S) body = 82.1/17.9]. This reaction solution was treated in the same manner as in Example 4, and N2- (1-ethoxycarbonyl-3-oxo-3-phenylpropyl) -N6-
65.0 g of trifluoroacetyl-L-lysine was obtained as crystals. [(S,S) body/(R,S) body=
81.9/18.1]. Example 7 13.1 ml of concentrated hydrochloric acid was added to 500 ml of ethanol, and to this was added the N 2 -(1-ethoxycarbonyl-3-oxo-3-phenylpropyl)-N 6 -trifluoroacetyl-L- obtained in Example 6. 35.0 g of lysine was added and dissolved, 10.5 g of 10% palladium carbon was added thereto, and hydrogenation was performed at 40° C. under normal pressure. After the reaction, the catalyst was suctioned off, the ethanol solution was adjusted to pH4.5 with sodium hydroxide, water was added,
Ethanol was distilled off by concentration under reduced pressure and replaced with water. Pass through the precipitated white crystals to obtain N2- (1-ethoxycarbonyl-3-phenylpropyl) -N6-
32.0 g of trifluoroacetyl-L-lysine was obtained. [(S,S) body/(R,S) body = 81.9/18.1].
This was recrystallized from water-ethanol to give N2- (1-
(S)-Ethoxycarbonyl-3-phenylpropyl) -N6 -trifluoroacetyl-L-lysine was obtained. 1H -NMR (90MHz, CDCl3 ): δ (ppm); 1.2~
1.43 (t, 3H), 1.42~2.25 (m, 8H), 2.5~2.85
(m, 2H), 3.0~3.55 (m, 4H), 4.05~4.35 (q,
2H), 6.9~7.4 (m, 5H) IR (cm -1 , KBr disk) 3320, 1740, 1700, 1615, 1205, 1170, 750, 700 mp 135.5~137.0℃ [α] 25 D = +7.8゜(c=2.0, EtOH) Example 8 8.16g of t-EBA was dissolved in 100ml of ethanol,
Add 9.69 g of L-Lys (Tfa) to this and suspend it, -
While maintaining the temperature at 5°C, 20.0 ml of N-LiOH aqueous solution was continuously added over 150 minutes with stirring. After addition, further
After continued stirring for 30 minutes, 10.0 ml of concentrated hydrochloric acid was added to stop the reaction. To this was added 130 ml of ethanol and 5.0 g of 10% palladium carbon, and hydrogenation was carried out at 40° C. under normal pressure. After the reaction, the catalyst was removed and treated in the same manner as in Example 7 to obtain 14.1 g of N2- (1-ethoxycarbonyl-3-phenylpropyl) -N6 -trifluoroacetyl-L-lysine. [(S,
S) body/(R,S) body = 82.0/18.0]. Reference example 4.08 g of t-EBA was dissolved in 50 ml of a solution of ethanol/water = 10/1, and 5.0 g of N 6 -benzyloxycarbonyl-L-lysine (L-Lys(z)) was added and suspended. At room temperature, lithium hydroxide monohydrate
0.75 g was added instantly, and stirring was continued for 1 hour. After the reaction was completed, 5.94 ml of concentrated hydrochloric acid was added, 2.0 g of 10% palladium carbon was added, and hydrogenation was carried out at 40° C. under normal pressure. After the reaction, the catalyst was removed, the pH was adjusted to 8.9 with sodium hydroxide, the solvent was distilled off under reduced pressure, ethanol was added to the residue for extraction, and insoluble materials were removed by filtration. The pH of the liquid was adjusted to 4.6 with hydrochloric acid, and the residue obtained by concentration under reduced pressure was crystallized with ether to give N 2 -(1-ethoxycarbonyl-3-phenylpropyl)-L-lysine hydrochloride 4.0 I got g.
Claims (1)
一般式() 〔式中、R2はアシル型保護基を表わす〕 で示されるL−リジンの誘導体とを、()と当
量の塩基を使用して反応させることを特徴とす
る、一般式() 〔式中、R1およびR2は前記と同じ〕 で示されるN2−(1−カルボキシ−3−オキソ−
3−フエニル)−L−リジン誘導体の製造法。 2 塩基として、アルカリ金属水酸化物、アルカ
リ金属炭酸塩、アルカリ土類金属水酸化物、四級
アンモニウム水酸化物、アミンまたはアンモニア
を用いる特許請求の範囲第1項記載の製造法。 3 L−リジン誘導体としてN6−トリフルオロ
アセチル−L−リジンを、β−ベンゾイルアクリ
ル酸誘導体としてtrans−β−ベンゾイルアクリ
ル酸エチルを用いる特許請求の範囲第1項または
第2項記載の製造法。 4 水酸化リチウム、水酸化ナトリウムまたは水
酸化カリウムを使用してN6−トリフルオロアセ
チル−L−リジンとtrans−β−ベンゾイルアク
リル酸エチルとを反応せしめ、N2−(1−(S)−
エトキシカルボニル−3−オキソ−3−フエニル
プロピル)−L−リジンを優先的に合成する特許
請求の範囲第1項乃至第3項の何れかの項記載の
製造法。 5 付加反応後、当量以上の鉱酸を添加し生成物
を安定化させる特許請求の範囲第1項乃至第4項
の何れかの項記載の製造法。 6 一般式() 〔式中、R1はアルキル基を表わす〕 で示されるβ−ベンゾイルアクリル酸誘導体と、
一般式() 〔式中、R2はアシル型保護基を表わす〕 で示されるL−リジンの誘導体とを、()と当
量の塩基を使用して反応させ、生じる一般式
() 〔式中、R1およびR2は前記と同じ〕 で示されるN2−(1−カルボキシ−3−オキソ−
3−フエニル)−L−リジン誘導体を接触水素化
分解した後、一般式() 〔式中、R1,R2は前記と同じ〕 で示されるN2−(1−カルボキシ−3−フエニル
プロピル)−L−リジン誘導体を製造する方法。 7 N2−(1−エトキシカルボニル−3−オキソ
−3−フエニルプロピル)−N6−トリフルオロア
セチル−L−リジンを接触水素化分解して、N2
−(1−エトキシカルボニル−3−フエニルプロ
ピル)−N6−トリフルオロアセチル−L−リジン
に変換する特許請求の範囲第6項記載の製造法。 8 一般式 〔式中、R1はアルキル基、R2はアシル型保護
基、X,Yは各々水素原子か、一緒に酸素原子を
表す〕 で表わされるN2−(1−カルボキシ−3−フエニ
ルプロピル)−L−リジン誘導体。 9 R2がトリフルオロアセチル基である特許請
求の範囲第8項記載のN2−(1−カルボキシ−3
−フエニルプロピル)−L−リジン誘導体。[Claims] 1 General formula () [In the formula, R 1 represents an alkyl group] A β-benzoyl acrylic acid derivative represented by the following:
General formula () [In the formula, R 2 represents an acyl-type protecting group] The general formula () is characterized by reacting the L-lysine derivative represented by () with an equivalent amount of base. [In the formula, R 1 and R 2 are the same as above] N 2 -(1-carboxy-3-oxo-
3-Phenyl)-L-lysine derivative manufacturing method. 2. The production method according to claim 1, in which an alkali metal hydroxide, an alkali metal carbonate, an alkaline earth metal hydroxide, a quaternary ammonium hydroxide, an amine, or ammonia is used as the base. 3. The manufacturing method according to claim 1 or 2, in which N 6 -trifluoroacetyl-L-lysine is used as the L-lysine derivative and ethyl trans-β-benzoylacrylate is used as the β-benzoylacrylic acid derivative. . 4 N 6 -trifluoroacetyl-L-lysine and ethyl trans-β-benzoylacrylate are reacted using lithium hydroxide, sodium hydroxide or potassium hydroxide, and N 2 -(1-(S)-
3. The manufacturing method according to any one of claims 1 to 3, which preferentially synthesizes ethoxycarbonyl-3-oxo-3-phenylpropyl)-L-lysine. 5. The production method according to any one of claims 1 to 4, wherein after the addition reaction, an equivalent or more amount of mineral acid is added to stabilize the product. 6 General formula () [In the formula, R 1 represents an alkyl group] A β-benzoyl acrylic acid derivative represented by the following:
General formula () [In the formula, R 2 represents an acyl-type protecting group] is reacted with the L-lysine derivative represented by () using an equivalent amount of base, resulting in the general formula () [In the formula, R 1 and R 2 are the same as above] N 2 -(1-carboxy-3-oxo-
After catalytic hydrogenolysis of the 3-phenyl)-L-lysine derivative, the general formula () [In the formula, R 1 and R 2 are the same as above] A method for producing an N 2 -(1-carboxy-3-phenylpropyl)-L-lysine derivative. 7 N2- (1-ethoxycarbonyl-3-oxo-3-phenylpropyl) -N6 -trifluoroacetyl-L-lysine is catalytically hydrogenolyzed to produce N2
7. The production method according to claim 6, wherein -(1-ethoxycarbonyl-3-phenylpropyl) -N6 -trifluoroacetyl-L-lysine is converted. 8 General formula [In the formula, R 1 is an alkyl group, R 2 is an acyl protecting group, and X and Y are each a hydrogen atom or together represent an oxygen atom] N 2 -(1-carboxy-3-phenylpropyl )-L-lysine derivative. 9 N 2 -(1-carboxy - 3
-phenylpropyl)-L-lysine derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62072589A JPH01104034A (en) | 1986-03-27 | 1987-03-26 | Production of n2-(1-carboxy-3-phenylpropyl)-l-lysine derivative |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61-68970 | 1986-03-27 | ||
JP6897086 | 1986-03-27 | ||
JP62072589A JPH01104034A (en) | 1986-03-27 | 1987-03-26 | Production of n2-(1-carboxy-3-phenylpropyl)-l-lysine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01104034A JPH01104034A (en) | 1989-04-21 |
JPH044308B2 true JPH044308B2 (en) | 1992-01-27 |
Family
ID=26410157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62072589A Granted JPH01104034A (en) | 1986-03-27 | 1987-03-26 | Production of n2-(1-carboxy-3-phenylpropyl)-l-lysine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01104034A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3792777B2 (en) * | 1996-05-10 | 2006-07-05 | 株式会社カネカ | Method for producing 1-alkoxycarbonyl-3-phenylpropyl derivative |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59118766A (en) * | 1982-12-16 | 1984-07-09 | ヘキスト・アクチエンゲゼルシヤフト | Cis, endo-2-azabicyclo(5,3,0)decane-3-carboxylic acid derivative and manufacture |
-
1987
- 1987-03-26 JP JP62072589A patent/JPH01104034A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59118766A (en) * | 1982-12-16 | 1984-07-09 | ヘキスト・アクチエンゲゼルシヤフト | Cis, endo-2-azabicyclo(5,3,0)decane-3-carboxylic acid derivative and manufacture |
Also Published As
Publication number | Publication date |
---|---|
JPH01104034A (en) | 1989-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4716235A (en) | Process for preparing N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline | |
SK164597A3 (en) | Method of making (s)-3-(aminomethyl)-5-methylhexanoic acid | |
JPH07304770A (en) | New benzazepinone derivative | |
AU2003224420B2 (en) | Process for preparation of perindopril and salts thereof | |
EP1140795B1 (en) | N-3, 3-dimethylbutyl-l-aspartic acid and esters thereof, the process of preparing the same, and the process for preparing n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine-1-methylester therefrom | |
US4925969A (en) | Process for preparing ethyl-alpha-amino-gamma-oxo-gamma-phenybutyrate derivatives | |
EP0239062B1 (en) | N2-(1-carboxy-3-oxo-3-phenylpropyl)-l-lysine compounds and their derivatives | |
JPH044308B2 (en) | ||
EP0823416B1 (en) | Process for producing cyclohexylamino acids | |
JPH11349567A (en) | Production of 3-amino-2-oxo-pyrrolidine, new intermediate and its use | |
EP1513868B1 (en) | Process for the production of lisinopril | |
FR2547816A1 (en) | PROCESS FOR THE SYNTHESIS OF ASPARTAME | |
JPH08157437A (en) | Production of d-amino acid-n-(s)-alpha-alkylbenzylamide | |
EP0902011B1 (en) | Gamma-oxo-homophenylalanine derivatives and process for producing homophenylalanine derivatives by reducing the same | |
IE872136L (en) | N(2)-(1-carboxy-3-oxo-3-phenylpropyl)-l-lysines | |
JPH08253497A (en) | Peptide-type compound | |
CA2236117C (en) | Process for producing optically active cyanohydrins | |
US5017690A (en) | Deblocking N-formyl aspartame compounds | |
JPH08259519A (en) | Production of alpha-aminoglycol and intermediate thereof | |
JP2598470B2 (en) | Method for producing N-benzyloxycarbonyl-α-L-aspartyl-L-phenylalanine methyl ester | |
JPH07121916B2 (en) | Optically active 3-acyl-2-oxoimidazolidine-4-carboxylic acid derivative and process for producing the same | |
JPH07639B2 (en) | Process for producing α-L-aspartyl-L-phenylalanine methyl ester or its hydrochloride | |
HU204540B (en) | Process for producing n-/n-(1(s)-ethoxycarbonyl-3-phenyl-propyl)-1-alanyl/-n-(indan-2-yl)- -glycine | |
JPH11100364A (en) | Production of high-purity n-protected s-phenylcysteine | |
JPH07119233B2 (en) | Method for synthesizing the bioactive substance probestin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080127 Year of fee payment: 16 |